Information  X 
Enter a valid email address

Aquila Euro Rnwbls. (AERS)

  Print      Mail a friend

Tuesday 11 February, 2020

Aquila Euro Rnwbls.

Dividend Declaration

RNS Number : 6534C
Aquila European Renewables Income
11 February 2020
 

11 February 2020

Aquila European Renewables Income Fund plc

 

Second Dividend Payment

 

The Board of Aquila European Renewables Income Fund plc ("AERIF" or the "Company") is pleased to announce the payment of its second dividend of 0.75 cents per Ordinary share payable in line with the target set out in the Company's prospectus for the period to 31 December 2019. The dividend will be paid on 20 March 2020 to shareholders who appear on the register on 21 February 2020.  The Company's Ordinary shares will be marked ex-dividend on 20 February 2020.

 

For further details contact:
 

Media contacts:


Smithfield Consultants

Ged Brumby | 020 3047 2527

John Kiely d Davis

David Benda

Vicki Paine

 

NOTES

Aquila European Renewables Income Fund ("AERIF" or the "Company") is a recently established, London-listed renewable energy infrastructure investment company with the aim to provide investors with an attractive long-term, income-based return in EUR through a diversified portfolio of hydropower, onshore wind and solar PV investments across continental Europe and Ireland. Through the diversification of generation technologies, the seasonal production patterns of these asset types complete each other to balance the cash flow, while the geographic diversification serves to reduce exposure to one single energy market. AERIF is targeting an aggregate annual yield of 5.0% once fully invested.

Further details can be found on AERIF 's website at www.aquila-european-renewables-income-fund.com.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DIVEAAAFFAEEEFA

a d v e r t i s e m e n t